Nilvadipine in mild to moderate Alzheimer disease: A randomised controlled trial

Lawlor, Brian; Segurado, Ricardo; Kennelly, Sean; Rikkert, Marcel G. M. Olde; Howard, Robert; Pasquier, Florence; Borjesson-Hanson, Anne; Tsolaki, Magda; Lucca, Ugo; Molloyid, D. William; Coen, Robert; Riepe, Matthias W.; Kalman, Janos; Kenny, Rose Anne; Cregg, Fiona; O'Dwyer, Sarah; Walsh, Cathal; Adams, Jessica; Banzi, Rita; Breuilh, Laetitia; Daly, Leslie; Hendrix, Suzanne; Aisen, Paul; Gaynor, Siobhan; Sheikhi, Ali; Taekema, Diana G.; Verhey, Frans R.; Nemni, Raffaello; Nobili, Flavio; Franceschi, Massimo; Frisoni, Giovanni; Zanetti, Orazio; Konsta, Anastasia; Anastasios, Orologas; Nenopoulou, Styliani; Tsolaki-Tagaraki, Fani; Pakaski, Magdolna; Dereeper, Olivier; de la Sayette, Vincent; Senechal, Olivier; Lavenu, Isabelle; Devendeville, Agnes; Calais, Gauthier; Crawford, Fiona; Mullan, Michael; NILVAD Study Grp

Erstveröffentlichung

2018

Authors

Lawlor, Brian

Segurado, Ricardo

Kennelly, Sean

Rikkert, Marcel G. M. Olde

Howard, Robert

et al.

Wissenschaftlicher Artikel

Published in

PLoS Medicine ; 15 (2018), 9. - Art.-Nr. e1002660. - ISSN 1549-1676

Link to publication

https://dx.doi.org/10.1371/journal.pmed.1002660

Institutions

Bezirkskrankenhaus Günzburg

EU Project uulm

NILVAD / A European multicentre double-blind placebo-controlled phase III trial of nilvadIpine in mild to moderate Alzheimer’s disease / EC / FP7 / 279093

Subject headings

[DDC subject group]: DDC 610 / Medicine & health

Metadata

Show full item record